36
Participants
Start Date
November 1, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
Blinatumomab
The 14-day blinatumomab combined with reduced-dose chemotherapy is used for the induction treatment of newly diagnosed Ph-chromosome negative acute B-lymphoblastic leukemia.
Shandong Provincial Hospital
OTHER_GOV
The Affiliated Hospital of Qingdao University
OTHER
Tangshan Central Hospital
OTHER
Affiliated Central Hospital of Shandong First Medical University
UNKNOWN
Yantai Yuhuangding Hospital
OTHER
Qilu Hospital of Shandong University (Qingdao)
OTHER
Qingdao Central Hospital
OTHER
Qingdao Municipal Hospital
OTHER
The Affiliated Hospital of Jining Medical University and Zaozhuang City
UNKNOWN
Affiliated Hospital of Binzhou Medical College
UNKNOWN
Linyi People's Hospital
OTHER
The Second Hospital of Shandong University
OTHER
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
OTHER
Shandong First Medical University
OTHER
Shengli Oilfield Hospital
OTHER
Heze Municipal Hospital
OTHER
Zibo Central Hospital
OTHER_GOV
Zaozhuang Municipal Hospital
OTHER
Weihai Municipal Hospital
OTHER
Shandong University
OTHER